1. Introduction: Redefining Success in Wound Care
In our clinical practice, we often face the profound frustration of wounds that simply will not close. For years, nursing education has focused on a “curative” model where healing is the only metric of success. However, as we move into the realm of palliative care, our primary mandate at the bedside must shift. We are not failing when a wound doesn’t heal at the end of life; we are succeeding when we maintain the patient’s dignity and comfort.
When physiological closure is no longer a realistic clinical goal, we redefine success through Health-Related Quality of Life (HRQoL). As defined in our evidence base (Source 2.7), HRQoL is a multidimensional outcome that balances two central pillars:
- Objective Functioning: The measurable capacity for the patient to engage in their environment.
- Subjective Well-being: The patient’s personal sense of satisfaction and their own perspective on the illness.
Redefining success means recognizing that a stable, non-odorous, and pain-free wound is a clinical triumph, even if that wound remains present until the patient’s final breath.
2. The Phenomenon of Skin Failure and Terminal Ulcers
We must recognize “Skin Failure” as a legitimate clinical diagnosis, distinct from pressure injuries caused by neglect. Skin failure occurs when the skin, as the body’s largest organ, begins to lose its integrity due to hypoperfusion and metabolic waste buildup concurrent with multiorgan dysfunction (Source 9.4).
The “SCALE” (Skin Changes At Life’s End) consensus provides us with a crucial framework: these injuries are often unavoidable. They occur because the dying body’s internal resources are diverted away from the periphery to maintain the core, meaning skin breakdown can occur even when our bedside care meets or exceeds every standard of practice.
Comparison of Terminal Skin Injuries
| Term | Clinical Appearance/Shape | Typical Location | Prognostic Significance |
| Kennedy Terminal Ulcer (KTU) | Pear, butterfly, or horseshoe-shaped; red, yellow, or black; irregular borders. | Predominantly sacrum or coccyx. | Life expectancy 2 weeks to several months; 55.7% die within 6 weeks of discovery. |
| 3:30 Syndrome | Small black spots (resembling dirt) or black/purple “marker” patches; may include blisters. | Unilateral location. | Rapid onset. Named for the transition from morning chair-positioning to the 3:30 PM return to bed; life expectancy 8–24 hours. |
| Trombley-Brennan Terminal Tissue Injury (TB-TTI) | Bruise-like (pink, purple, or maroon); may present as linear striations or butterfly shapes. | Bony prominences, shins, thighs, or spine; often presents in “mirror images.” | Rapid evolution; 75% of patients die within 72 hours of identification. |
3. Clinical Management: The “5 P’s” and Priority Symptoms
To navigate these complex cases, we utilize the 5 P’s framework: Prevention, Prescription, Preservation, Palliation, and Preference. In the palliative model, “Preference” is paramount. If a standard turning schedule causes excruciating pain for a patient in their final hours, the clinical choice to forgo that turn in favor of comfort is not only valid—it is the highest form of care (Source 9.4).
Odor Control: A Matter of Dignity
Wound malodor is one of the most distressing symptoms for patients and families. It is caused by anaerobic bacteria and metabolic byproducts like putrescine. While “off-label,” the clinical standard for CNCs is the use of topical metronidazole (Source 9.8).
- Application: Apply a 0.75% to 1% gel or solution directly to the wound.
- Mechanism: It acts as a bactericide, targeting the DNA of anaerobic organisms to eliminate odor at the source rather than merely masking it.
Exudate and Infection: Managing the Metabolic Load
We must distinguish between contamination (the presence of surface bacteria) and infection (tissue invasion). Excessive bioburden creates a “metabolic load”—the bacteria are essentially “stealing” the body’s limited oxygen and nutrients (Source 4.16). This explains why aggressive feeding often fails to close these wounds; the nutrients never reach the tissue because the bioburden consumes them first.
Pain Reduction: The Prerequisite for Care
The Swedish Study (Source 9.6) provides a vital clinical pearl: better pain control directly correlates with lower-category pressure injuries. This is because pain-free patients are more receptive to repositioning and remain more mobile. Pain relief is a prerequisite for tissue preservation, not just a byproduct of it.
- Strategy: Use “micro-repositioning” (small shifts) and time analgesics so they reach peak effectiveness prior to dressing changes or movement.
4. Specialized Focus: Fungating Wounds and Pressure at Life’s End
Malignant fungating wounds carry a unique psychosocial weight. Patients often suffer from deep social stigma, guilt, and shame (Source 2.7), leading to profound isolation. Our role is to provide a “safe harbor” through meticulous symptom management that allows the patient to engage with their loved ones without fear of odor or leakage.
End-of-life pressure injuries often appear with startling speed, presenting as maroon, purple, or black areas of intact skin (Source 9.4). These are reflective of deep tissue compromise. In these moments, our focus shifts from “fixing” the skin to preserving the “Circle of Care.”
5. Psychosocial Support and the “Circle of Care”
Effective palliative wound care is built on a foundation of mutual trust and attentive listening.
- Transparent Communication: We must educate families that terminal ulcers are part of the body’s natural physiological decline. When we explain the unavoidable nature of SCALE, we alleviate the guilt family members feel when they see skin breakdown despite their best efforts.
- Practice Pearls: Listen for specific patient concerns regarding body image, loss of independence, and isolation. Our presence at the bedside is often as therapeutic as the dressings we apply.
6. Conclusion: Dignity in the Final Days
Our mission as palliative nurses is to optimize well-being when healing is no longer a possibility. By recognizing skin failure as a legitimate clinical event and centering our plans on the patient’s comfort and preferences, we uphold the dignity of those in our care. We succeed when the final days are defined by the quality of the relationship and the absence of distress, rather than the closure of a wound.
7. Quick Reference: Clinical Indicators for Palliative Care Nurses
The following cofactors impair healing and signal skin compromise. Nurses should look for these specific indicators during holistic assessments:
Physiological Factors
- Subclinical Hypovolemia: Detected by capillary refill at the forehead (< 3 seconds) or prepatellar knee (< 5 seconds). This condition is often undetectable by standard vital signs but indicates that tissues are under-perfused (Source 4.16).
- The Smoking Triad: The interaction of nicotine (vasoconstriction), carbon monoxide (reduced oxygen-carrying capacity), and hydrogen cyanide (inhibition of oxidative metabolism) (Source 4.16).
- Oxygenation: Insufficient dissolved oxygen prevents collagen formation and inhibits bacterial killing by leukocytes.
- Age: Reduced dermal vascularity and a slowed inflammatory response.
- Nutritional Status: Malnutrition or low protein intake diverts energy away from tissue maintenance to essential cellular survival.
Psychological & Stress Factors
- Psychophysiological Stress: High cortisol levels and pain trigger vasoconstriction, directly reducing blood flow to the skin.
- Pain: Chronic pain correlates with higher risk for skin breakdown due to decreased patient mobility.
Iatrogenic & Disease Factors
- Concomitant Conditions: Diabetes, vascular disease, and malignancy significantly increase the “metabolic load” and risk of skin failure.
- Adverse Effects of Therapy: Radiation (fibrosis), chemotherapy (interruption of cell mitosis), and steroids (suppression of the inflammatory response).
- Old Wound Tissue: The presence of senescent fibroblasts and scar tissue that no longer responds to standard growth signals.